Commercially launched in September 1994, Sangini, a three monthly injectable, is most widely used family planning method among other reversible methods. Each ml of Sangini is comprised of Medroxyprogesterone Acetate 150 mg. Sangini is a temporary contraceptive that is convenient, reliable, affordable, and professionally administered. Its targeted customers are women of age group 18-35 who want to come off the pill and yet are not ready for long term contraception. Sangini is provided by trained service providers who undergo 3 days Sangini Basic Training and Refreshers Training provided to Service Providers; and it’s available in 3,381 selected and trained medical outlets of 75 districts.
